What We've Done - Population Genetics Technologies, Ltd.
Population Genetics Technologies, Ltd. (PGT) has developed and patented technologies that can quickly and economically find, characterize, and quantify true genetic variants responsible for disease, disease resistance, and drug response. These technologies are all based on inventions conceived by Sydney Brenner and were originally assigned to Compass Genetics LLC, co-founded by Sydney Brenner, Sam Eletr, and Philip Goelet, which funded initial reduction to practice research in Acidophil’s laboratory. PGT began independent operations in the UK in mid-2005 upon receipt of a translational grant from the Wellcome Trust and transfer of intellectual property from Compass Genetics. Since then PGT has raised capital from seed, Series A, and Series B financings.